Bota Biosciences
Bota Biosciences supplies food biopreservatives and nutrition through Helia Genesis, plus beauty/personal-care ingredients through Yucca Elements, using clean biomanufacturing.
- Company
Bota Biosciences supplies food biopreservatives and nutrition through Helia Genesis, plus beauty/personal-care ingredients through Yucca Elements, using clean biomanufacturing.
bota.bioCrawled Oct 15, 2026
Bota uses Colony PCR to screen hundreds of genome transformation designs weekly. The technique rapidly screens bacterial colonies for successful gene insertion or knockout after cloning.
Bota’s in-house-developed Bota Biofoundry platform expedites work throughout the DBTL cycle; the research bottleneck is generating new ideas rather than planning, preparing, and executing experiments.
Bota Biosciences announced a five-year strategic partnership with Syensqo to combine Bota’s performance protein platform with Syensqo’s expertise in hair.
Bota Biosciences announced its participation in Food Ingredients Europe 2024, scheduled for November 19–21 in Frankfurt, Germany.
The 15th Annual Meeting of the New Champions was held in Dalian, China, from June 25 to 27, 2024, and gathered over 1,500 participants from politics, business, social groups, international organizations, academia, and media.
Bota Biofoundry is an independently developed, end-to-end biofoundry platform spanning concept to mass production.
The address is Building 22, Biopharma Town IV, Hangzhou, China.
Bota Biofoundry combines computer algorithms and biotechnologies to accelerate DBTL cycles and enable cleaner, more efficient biomanufacturing.
Bota hosts a SynBioBeta delegation to showcase its AI-driven biomanufacturing capabilities. The visit includes biotech firms, research institutions, and investors examining how AI integrates with physical production processes. Delegates explore applications in synthetic biology and cross-border collaboration.
Jul 2026Bota | 恩和科技News article
Bota Biosciences and BASF launch **SkinNexus™ Collag3n**, a 100% human-identical recombinant **Collagen III** product. The collaboration leverages **AI-driven precision** to develop a bio-identical alternative for skin health applications. BASF’s new formulation aims to address market demand for advanced biomaterials in dermatology and regenerative medicine.
Jun 2026PR NewswireNews article
BASF launches **SkinNexus™ Collag3n**, a 100% human-identical recombinant **Collagen III** fragment developed with **Bota Biosciences**. The product targets the **personal care market** and marks the first commercial application of their collaborative AI-driven research. BASF will handle commercialization, leveraging the fragment’s bio-identical properties for skincare applications.
Jun 2026basf.comNews article
Bota Biosciences introduces **Biology Protocol Language (BPL)**, a compiler-verified programming language for AI-driven biomanufacturing. The company also unveils **BPL-COGEN**, a generation pipeline for BPL, and is selected for the **World Economic Forum’s MINDS program 2026**, recognizing its Physical AI biomanufacturing advancements as a validated industrial AI deployment.
Jun 2026PR NewswireNews article